Beyond Testing: How Clinical Laboratory Services Influence Drug Development Outcomes
This guest editorial is by Pooja Dhoundiyal, Research Manager, Vyansa Intelligence Drug development is becoming increasingly dependent on the ability to generate reliable biological evidence
Supplier Management Has a People Problem, 2026 Research Finds
“The worst-performing pillar every year is people,” says Alan Day. Alan Day, Chairman and Founder of State of Flux, presented the findings of the 2026
Hikal Signs Multi-Year CDMO Agreement With European Agrochemical Firm After Nearly Three Years of Joint Development
Hikal Limited has signed a multi-year contract development and manufacturing agreement with a Europe-based global agrochemical company. The deal was reported on November 2, 2026. Under
Akums Posts 31.9% Revenue Growth in Q2 FY27 as CDMO Volumes Drive Outsourcing Expansion
Akums Drugs and Pharmaceuticals Limited reported strong second-quarter FY27 results, presented to investors on November 3, 2026. Consolidated revenue reached ₹1,342 crore, up 31.9% year over
Shilpa CDMO Invests $50M to Scale Peptide Manufacturing, With First Commercial Line Opening December 2026
Shilpa CDMO, the complex-chemistry contract development and manufacturing arm of Shilpa Medicare, announced on November 3, 2026, that it is investing $50 million to expand
Evestia Clinical Acquires Belgian Medical Writing Specialist Emtex Life Science to Expand European CRO Presence
Evestia Clinical, a leading independent global specialist CRO, announced on November 3, 2026, from London, that it has acquired Emtex Life Science, a specialist regulatory
Merck Opens $336M Bioprocessing Production Center in South Korea
Merck has opened its new Asia-Pacific Bioprocessing Production Center in Daejeon, South Korea, following an investment of more than €300 million. The 44,500-square-meter facility represents
Lonza to Acquire Merck CDMO Operations Across Five US Locations
Lonza has signed a definitive agreement to acquire the contract development and manufacturing organization (CDMO) business within Merck’s Life Science sector for a mid-triple-digit million-euro
Coriolis Pharma Appoints Dr. Teun van der Heide as CEO
Coriolis Pharma has appointed Dr. Teun van der Heide as chief executive officer, effective November 2, 2026. The appointment brings a new executive leader to
AKEURA Launches as Specialist CRO Combining Clinical Development and Real-World Evidence After P95 and Julius Clinical Integration
AKEURA, formerly P95 Julius Clinical, launched on November 2, 2026, as a global specialist CRO with dual expertise in clinical and real-world settings. The new